This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
Plans underway to expand screening capacity by 50% for greater accessibility
Expansion makes Merck Life Science in Bengaluru a key manufacturing location in the APAC region
The inspection scope had included six separate Biologics manufacturing units comprising of four Drug Substance and two Drug Product manufacturing plants
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
The inspection scope included 6 separate Biologics manufacturing units comprising 4 Drug Substance and 2 Drug Product manufacturing plants
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Subscribe To Our Newsletter & Stay Updated
